Cargando…
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
Aberrant activation of anaplastic lymphoma kinase (ALK) has been described in a range of human cancers, including non-small cell lung cancer and neuroblastoma (Hallberg and Palmer, 2013). Vertebrate ALK has been considered to be an orphan receptor and the identity of the ALK ligand(s) is a critical...
Autores principales: | Guan, Jikui, Umapathy, Ganesh, Yamazaki, Yasuo, Wolfstetter, Georg, Mendoza, Patricia, Pfeifer, Kathrin, Mohammed, Ateequrrahman, Hugosson, Fredrik, Zhang, Hongbing, Hsu, Amy W, Halenbeck, Robert, Hallberg, Bengt, Palmer, Ruth H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658194/ https://www.ncbi.nlm.nih.gov/pubmed/26418745 http://dx.doi.org/10.7554/eLife.09811 |
Ejemplares similares
-
Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent
por: Guan, Jikui, et al.
Publicado: (2016) -
Targeting anaplastic lymphoma kinase in neuroblastoma
por: Umapathy, Ganesh, et al.
Publicado: (2019) -
The FAM86 domain of FAM86A confers substrate specificity to promote EEF2-Lys525 methylation
por: Francis, Joel William, et al.
Publicado: (2023) -
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice
por: Siaw, Joachim T., et al.
Publicado: (2016) -
FAM20A binds to and regulates FAM20C localization
por: Ohyama, Yoshio, et al.
Publicado: (2016)